| Primary |
| Type 2 Diabetes Mellitus |
77.6% |
| Diabetes Mellitus |
7.8% |
| Hypertension |
3.9% |
| Insulin-requiring Type 2 Diabetes Mellitus |
3.6% |
| Blood Cholesterol Increased |
1.2% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Blood Pressure |
0.6% |
| Cardiac Disorder |
0.5% |
| Anxiety |
0.4% |
| Blood Cholesterol |
0.4% |
| Depression |
0.4% |
| Hyperlipidaemia |
0.4% |
| Prophylaxis |
0.4% |
| Glucose Tolerance Impaired |
0.3% |
| Hypothyroidism |
0.3% |
| Blood Glucose Increased |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Insulin Resistance |
0.3% |
| Thyroid Disorder |
0.3% |
| Type 1 Diabetes Mellitus |
0.3% |
|
| Weight Decreased |
13.3% |
| Injection Site Nodule |
11.1% |
| Injection Site Pain |
9.6% |
| Injection Site Swelling |
7.6% |
| Injection Site Haemorrhage |
7.4% |
| Blood Glucose Increased |
5.9% |
| Injection Site Pruritus |
5.7% |
| Nausea |
5.5% |
| Vomiting |
5.4% |
| Pancreatitis |
5.2% |
| Injection Site Mass |
4.5% |
| Off Label Use |
3.3% |
| Product Quality Issue |
2.9% |
| Underdose |
2.8% |
| Urticaria |
2.6% |
| Injection Site Reaction |
2.0% |
| Weight Increased |
1.7% |
| Injection Site Extravasation |
1.4% |
| Diarrhoea |
1.2% |
| Rash |
0.9% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
64.8% |
| Insulin-requiring Type 2 Diabetes Mellitus |
6.3% |
| Product Used For Unknown Indication |
5.6% |
| Hypertension |
5.2% |
| Anxiety |
2.6% |
| Blood Glucose Increased |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Weight Decreased |
1.5% |
| Arthritis |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Cardiac Disorder |
1.1% |
| Depression |
1.1% |
| Diabetic Neuropathy |
1.1% |
| Mineral Supplementation |
1.1% |
| Atrial Fibrillation |
0.7% |
| Herpes Zoster |
0.7% |
| Hypothyroidism |
0.7% |
| Ankylosing Spondylitis |
0.4% |
| Back Pain |
0.4% |
|
| Weight Decreased |
30.8% |
| Pancreatic Carcinoma |
10.8% |
| Off Label Use |
7.7% |
| Injection Site Pruritus |
6.2% |
| Glycosylated Haemoglobin Increased |
4.6% |
| Nausea |
4.6% |
| Weight Increased |
4.6% |
| Adenocarcinoma Pancreas |
3.1% |
| Drug Dose Omission |
3.1% |
| Drug Ineffective |
3.1% |
| Hypoglycaemia |
3.1% |
| Malaise |
3.1% |
| Uterine Cancer |
3.1% |
| Vomiting |
3.1% |
| Arrhythmia |
1.5% |
| Blood Test Abnormal |
1.5% |
| Cholelithiasis |
1.5% |
| Coronary Angioplasty |
1.5% |
| Fall |
1.5% |
| Flatulence |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Diabetes Mellitus |
23.7% |
| Type 2 Diabetes Mellitus |
9.2% |
| Hypertension |
7.2% |
| Blood Cholesterol Increased |
6.6% |
| Blood Pressure |
3.3% |
| Psoriasis |
2.6% |
| Psoriatic Arthropathy |
2.6% |
| Blood Cholesterol |
2.0% |
| Chronic Hepatitis C |
2.0% |
| Hepatitis C |
2.0% |
| Migraine |
2.0% |
| Prostatic Disorder |
2.0% |
| Back Pain |
1.3% |
| Blood Triglycerides Increased |
1.3% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Fatigue |
1.3% |
| Pain |
1.3% |
| Prophylaxis |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Blood Glucose Increased |
7.7% |
| Muscle Spasms |
7.7% |
| Pain In Extremity |
7.7% |
| Product Quality Issue |
7.7% |
| Sinusitis |
7.7% |
| Weight Increased |
7.7% |
| Blood Glucose Abnormal |
3.8% |
| Blood Glucose Decreased |
3.8% |
| Clostridium Difficile Infection |
3.8% |
| Convulsion |
3.8% |
| Drug Ineffective |
3.8% |
| Heart Rate Abnormal |
3.8% |
| Injection Site Pain |
3.8% |
| Menopause |
3.8% |
| Mood Swings |
3.8% |
| Nausea |
3.8% |
| Osteopenia |
3.8% |
| Pain |
3.8% |
| Pancreatitis |
3.8% |
| Prostate Cancer |
3.8% |
|
| Interacting |
| Product Used For Unknown Indication |
70.0% |
| Type 2 Diabetes Mellitus |
20.0% |
| Herpes Zoster |
10.0% |
|
|
